Journal Logo

Poster Session II: Myeloma and other monoclonal gammopathies – Clinica

PS1390 PRELIMINARY DATA: PHASE 1B STUDY OF FEASIBILITY/SAFETY OF ISATUXIMAB SHORT DURATION FIXED VOLUME INFUSION IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

Usmani, S.1; Karanes, C.2; Bensinger, W.3; D'Souza, A.4; Raje, N.5; Tuchman, S.6; Kanagavel, D.7; Zhou, Y.8; Campana, F.8; Richardson, P.9

Author Information
doi: 10.1097/01.HS9.0000563836.49132.cf
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.